JPMorgan raised the firm’s price target on Omnicell (OMCL) to $44 from $37 and keeps a Neutral rating on the shares. The firm updated the company’s model post the Q3 report.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter